Skip to main content
SpringerLink
Log in

Clinical, economic, and organizational impact of pharmacists’ interventions in a cognitive-behavioral unit in France

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Objective Evaluate the clinical, economic, and organizational impact of pharmaceutical interventions performed during medication review in a cognitive-behavioral unit. Setting Study conducted in a cognitive-behavioral unit with retrospective data from January 2011 to june 2017. Methods This study was conducted from retrospective data of medication review in a cognitive-behavioral unit. During medication review, pharmacists identified relevant drug related problems lead to a pharmaceutical intervention which is submitted to the physician. All pharmaceutical interventions carried out from January 2011 to june 2017 were retrospectively analyzed to evaluate their clinical, economic and organizational impact using a multidimensional tool. Main outcome measure CLinical, Economic and Organizational impact using the CLEO tool. Results During the study period, 543 drug related problems and pharmaceutical interventions were recorded for patients hospitalized in the cognitive-behavioral unit (79.0 ± 9.5 years, 59% female). The most common types of drug related problems identified were ‘non conformity to guidelines / contra-indication’ (28.7%), ‘drug without indication’ (21.7%), and ‘improper administration’ (15.1%). The majority of pharmaceutical interventions were considered to have at least a clinical significant impact from the pharmacist’s perspective (74%). Regarding the economic and organizational dimensions, 55.2% of pharmaceutical interventions would decrease the costs of care and 35.9% of pharmaceutical interventions would be favorable on the quality of care process. Conclusions The present study shows that the pharmacist may detect a high number of drug related problems with significant clinical relevance during medication review in a cognitive-behavioral unit. Describing and identifying significant pharmaceutical interventions in cognitive-behavioral unit patients allow us to better understand and improve clinical practice in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Strubel D. The specificities of care in cognitive-behavior units. Soins Gerontol. 2015;20(113):37–42.

    Article  Google Scholar 

  2. Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. The Lancet. 2013;381(9882):2016–23.

    Article  Google Scholar 

  3. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.

    Article  Google Scholar 

  4. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012;10(3):165–77.

    Article  Google Scholar 

  5. Pasqualetti G, Tognini S, Calsolaro V, Polini A, Monzani F. Potential drug-drug interactions in Alzheimer patients with behavioral symptoms. Clin Interv Aging. 2015;10:1457–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Johnell K. Inappropriate drug use in people with cognitive impairment and dementia: a systematic review. Curr Clin Pharmacol. 2015;10(3):178–84.

    Article  Google Scholar 

  7. Sönnerstam E, Sjölander M, Lövheim H, Gustafsson M. Clinically relevant drug-drug interactions among elderly people with dementia. Eur J Clin Pharmacol. 2018;74(10):1351–60.

    Article  Google Scholar 

  8. Bonfiglio V, Umegaki H, Kuzuya M. Potentially inappropriate medications and polypharmacy: a study of older people with mild cognitive impairment and mild dementia. J Alzheimers Dis (JAD). 2019;71(3):889–97.

    Article  CAS  Google Scholar 

  9. Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, et al. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018;40(5):1199–208.

    Article  Google Scholar 

  10. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859–67.

    Article  Google Scholar 

  11. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.

    Article  Google Scholar 

  12. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.

    Article  Google Scholar 

  13. Mulvogue K, Roberts JA, Coombes I, Cottrell N, Kanagarajah S, Smith A. The effect of pharmacists on ward rounds measured by the STOPP/START tool in a specialized geriatric unit. J Clin Pharm Ther. 2017;42(2):178–84.

    Article  CAS  Google Scholar 

  14. El Morabet N, Uitvlugt EB, van den Bemt BJF, van den Bemt PMLA, Janssen MJA, Karapinar-Çarkit F. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8.

    Article  Google Scholar 

  15. Vo T-H, Charpiat B, Catoire C, Juste M, Roubille R, Rose F-X, et al. Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review. Drug Saf. 2016;39(2):131–46.

    Article  Google Scholar 

  16. Allenet B, Bedouch P, Rose F-X, Escofier L, Roubille R, Charpiat B, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci PWS. 2006;28(4):181–8.

    Article  Google Scholar 

  17. Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose F-X, et al. Trends in pharmacists’ medication order review in French hospitals from 2006 to 2009: analysis of pharmacists’ interventions from the Act-IP© website observatory. J Clin Pharm Ther. 2015;40(1):32–40.

    Article  CAS  Google Scholar 

  18. Vo T. Evaluation of the potential impact of pharmacist interventions: development and validation of the CLEO multidimensional tool. [Internet]. Université Grenoble Alpes, France; 2015. https://tel.archives-ouvertes.fr/tel-01315619/document

  19. Stämpfli D, Baumgartner P, Boeni F, Bedouch P, Lampert ML, Hersberger KE. Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions. Int J Clin Pharm. 2019;41(1):56–64.

    Article  Google Scholar 

  20. Mouchoux C, Viprey M, Loue C, Ottomani H, Bezel C, Divoux E, et al. Intégration du pharmacien-clinicien dans l’optimisation thérapeutique des patients avec troubles neurocognitifs pris en charge en unité cognitivocomportementale. Cah Année Gérontologique. 2014;6(2):37–43.

    Article  Google Scholar 

  21. Ziane A, Ngami C, Youb R, Atri MH, Aikpa R, Kabirian F, et al. Evaluating the quality of pharmacists’ interventions in older patient than 75 years. J Pharm Clin. 2013;32(4):243–9.

    Google Scholar 

  22. Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging. 2016;11:1343–50.

    Article  CAS  Google Scholar 

  23. Nguyen TA, Gilmartin-Thomas J, Tan ECK, Kalisch-Ellett L, Eshetie T, Gillam M, et al. The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review. J Alzheimers Dis. 2019;71(1):83–96.

    Article  CAS  Google Scholar 

  24. Novais T, Mouchoux C. Pharmaceutical care for patients and their caregivers in Alzheimer’s disease and related disorders: a review and new perspectives. Geriatr Psychol Neuropsychiatr Vieil. 2019;17(1):7–19.

    PubMed  Google Scholar 

  25. Sjölander M, Lindholm L, Pfister B, Jonsson J, Schneede J, Lövheim H, et al. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: an economic evaluation. Res Soc Adm Pharm. 2019;15(3):287–91.

    Article  Google Scholar 

  26. Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988;22(3):252–9.

    Article  CAS  Google Scholar 

  27. Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health Syst Pharm. 2001;58(9):784–90.

    Article  CAS  Google Scholar 

  28. Bosma L, Jansman FGA, Franken AM, Harting JW, Van den Bemt PMLA. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci PWS. 2008;30(1):31–8.

    Article  Google Scholar 

  29. Yailian A-L, Revel E, Tardy C, Fontana A, Estublier C, Decullier E, et al. Assessment of the clinical relevance of pharmacists’ interventions performed during medication review in a rheumatology ward. Eur J Intern Med. 2019;59:91–6.

    Article  Google Scholar 

  30. Pérez-Moreno MA, Rodríguez-Camacho JM, Calderón-Hernanz B, Comas-Díaz B, Tarradas-Torras J. Clinical relevance of pharmacist intervention in an emergency department. Emerg Med J EMJ. 2017;34(8):495–501.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the medical team of the cognitive-behavioral unit (Charpennes Hospital, Lyon Institute For Elderly, University Hospital of Lyon).

Funding

None.

Author information

Authors and Affiliations

  1. Pharmaceutical Unit, Charpennes Hospital, University Hospital of Lyon, Lyon, France

    Teddy Novais, Fanny Maldonado, Maxime Grail & Christelle Mouchoux

  2. University Lyon 1, Lyon, France

    Teddy Novais, Pierre Krolak-Salmon & Christelle Mouchoux

  3. EA-7425 HESPER, Health Services and Performance Research, University Lyon, Lyon, France

    Teddy Novais

  4. Clinical and Research Memory Centre of Lyon (CMRR), Charpennes Hospital, University Hospital of Lyon, Lyon, France

    Pierre Krolak-Salmon

  5. Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, INSERM U1028, CNRS UMR5292, Lyon, France

    Pierre Krolak-Salmon & Christelle Mouchoux

Authors
  1. Teddy Novais
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fanny Maldonado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maxime Grail
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierre Krolak-Salmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christelle Mouchoux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teddy Novais.

Ethics declarations

Conflicts of interest

The authors have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novais, T., Maldonado, F., Grail, M. et al. Clinical, economic, and organizational impact of pharmacists’ interventions in a cognitive-behavioral unit in France. Int J Clin Pharm 43, 613–620 (2021). https://doi.org/10.1007/s11096-020-01172-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-020-01172-4

Keywords

Search

Navigation